Neonatal adiposity following maternal treatment of gestational diabetes with glyburide compared with insulin

American Journal of Obstetrics and Gynecology

Volumn 200, Issue 5, 2009, Pages 501.e1-501.e6

  Lain, Kristine Y ^a   Garabedian, Matthew J ^a   Daftary, Ashi ^b   Jeyabalan, Arun ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

fetal fat mass; gestational diabetes; glyburide; randomized clinical trial; treatment

Indexed keywords

BIOLOGICAL MARKER; GLIBENCLAMIDE; INSULIN;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD LEVEL; BODY COMPOSITION; BODY FAT; BODY MASS; CHI SQUARE TEST; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG SUBSTITUTION; FEMALE; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; MALE; NEWBORN; OBESITY; PARAMETER; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; SKINFOLD THICKNESS; STUDENT T TEST; UMBILICAL CORD BLOOD; UNSPECIFIED SIDE EFFECT; WEIGHT INDEX;

EID: 64249099620     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2009.02.038     Document Type: Article

References (25)

1. Crowther C.A., Hiller J.E., Moss J.R., McPhee A.J., Jeffries W.S., and Robinson J.S. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 352 (2005) 2477-2486
2. Langer O., Conway D.L., Berkus M.D., Xenakis E.M., and Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. [see comment]. N Engl J Med 343 (2000) 1134-1138
3. Fines V., Moore T., and Castle S. A comparison of glyburide and insulin treatment in gestational diabetes mellitus on infant birth weight and adiposity. Am J Obstet Gynecol 189 (2003) S108
4. Jacobson G.F., Ramos G.A., Ching J.Y., Kirby R.S., Ferrara A., and Field D.R. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. [see comment]. Am J Obstet Gynecol 193 (2005) 118-124
5. Langer O., Yogev Y., Xenakis E.M.J., and Rosenn B. Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome. Am J Obstet Gynecol 192 (2005) 134-139
6. Ogunyemi D., Jesse M., and Davidson M. Comparison of glyburide versus insulin in management of gestational diabetes mellitus. [see comment]. Endocr Pract 13 (2007) 427-428
7. Chmait R., Dinise T., and Moore T. Prospective observational study to establish predictors of glyburide success in women with gestational diabetes mellitus. J Perinatol 24 (2004) 617-622
8. Kahn B.F., Davies J.K., Lynch A.M., Reynolds R.M., and Barbour L.A. Predictors of glyburide failure in the treatment of gestational diabetes. Am J Obstet Gynecol 107 (2006) 1303-1309
9. Rochon M., Rand L., Roth L., and Gaddipati S. Glyburide for the management of gestational diabetes: risk factors predictive of failure and associated pregnancy outcomes. Am J Obstet Gynecol 195 (2006) 1090-1094
10. Carpenter M.W., and Coustan D.R. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 144 (1982) 768-773
11. Behnke A.R., and Wilmore J.H. Evaluation and regulation of body build and composition (1974), Prentice-Hall Inc, Englewood Cliffs, NJ
12. Fiorotto M.L., and Klish W.J. Total body electrical conductivity measurements in the neonate. Clin Perinatol 18 (1991) 611-627
13. Fiorotto M.L., de Bruin N.C., Brans Y.W., Degenhart H.J., and Visser H.K. Total body electrical conductivity measurements: an evaluation of current instrumentation for infants. Pediatr Res 37 (1995) 94-100
14. Cochran W.J., Wong W.W., Fiorotto M.L., Sheng H.P., Klein P.D., and Klish W.J. Total body water estimated by measuring total-body electrical conductivity. Am J Clin Nutr 48 (1988) 946-950
15. Fiorotto M.L., Cochran W.J., Funk R.C., Sheng H.P., and Klish W.J. Total body electrical conductivity measurements: effects of body composition and geometry. Am J Physiol 252 (1987) R794-R800
16. Gilmour C.H., Taylor P.M., and Brown D.R. New and population-specific birthweight standards. Pediatr Res 31 (1992) 248
17. Ogata E.S. Perinatal morbidity in offspring of diabetic mothers. Diabetes Rev 3 (1995) 652-657
18. Persson B., and Hanson U. Neonatal morbidities in gestational diabetes mellitus. Diabetes Care 21 (1998) B79-B84
19. Catalano P.M., Thomas A., Huston-Presley L., and Amini S.B. Increased fetal adiposity: a very sensitive marker of abnormal in utero development. Am J Obstet Gynecol 189 (2003) 1698-1704
20. Catalano P.M., Thomas A.J., Avallone D.A., and Amini S.B. Anthropometric estimation of neonatal body composition. Am J Obstet Gynecol 173 (1995) 1176-1181
21. Cochran W.J., Fiorotto M.L., Sheng H.P., and Klish W.J. Reliability of fat-free mass estimates derived from total-body electrical conductivity measurements as influenced by changes in extracellular fluid volume. Am J Clin Nutri 49 (1989) 29-32
22. Durnwald C., Huston-Presley L., Amini S., and Catalano P. Evaluation of body composition of large-for-gestational-age infants of women with gestational diabetes mellitus compared with women with normal glucose tolerance levels. Am J Obstet Gynecol 191 (2004) 804-808
23. Cochran W.J., Klish W.J., Wong W.W., and Klein P.D. Total body electrical conductivity used to determine body composition in infants. Pediatr Res 20 (1986) 561-564
24. Moretti M.E., Rezvani M., and Koren G. Safety of glyburide for gestational diabetes: a meta-analysis of pregnancy outcomes. Ann Pharmacother 42 (2008) 483-490
25. Pirc L.K., Owens J.A., Crowther C.A., Willson K., De Blasio M.J., and Robinson J.S. Mild gestational diabetes in pregnancy and the adipoinsular axis in babies born to mothers in the ACHOIS randomised controlled trial. BMC Pediatr 7 (2007) 18